Cold agglutinin disease (CAD) is marked by the destruction of red blood cells, cells essential to transporting oxygen to…
Brian Murphy, Ph.D.
Brian holds a Ph.D. in Biomedical Engineering from Case Western Reserve University and a Bachelors of Science in Biomedical Engineering from Georgia Institute of Technology. He has co-authored numerous scientific articles based on his previous research in the field of brain-computer interfaces and functional electrical stimulation. He is also passionate about making scientific advances easily accessible to the public.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Brian Murphy, Ph.D.
Cold agglutinin disease (CAD) is a rare disorder in which the immune system produces autoantibodies that attack the body’s…
Your CAD Treatment Team
If you are diagnosed with cold agglutinin disease (CAD), it is important to see a multidisciplinary treatment team of…
CAD and Anesthesia
For cold agglutinin disease (CAD) patients who may need to undergo surgery, certain complications can occur as a result…
Warm Heart Surgery for Cold Agglutinin Disease
People with cold agglutinin disease (CAD) who need heart surgery may find that it poses extra risk. It is…
Side Effects of Rituximab for CAD
Cold agglutinin disease (CAD) is an autoimmune disorder where the body attacks its red blood cells during exposure to…
Prevalence of Cold Agglutinin Disease Worldwide
Cold agglutinin disease (CAD) cases have been reported in multiple nations across the world. There have been studies over…
A leading treatment for cold agglutinin disease (CAD) is rituximab. Following  are answers to some questions you might…